BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20807602)

  • 1. Targeted systemic gene therapy and molecular imaging of cancer contribution of the vascular-targeted AAVP vector.
    Hajitou A
    Adv Genet; 2010; 69():65-82. PubMed ID: 20807602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and construction of targeted AAVP vectors for mammalian cell transduction.
    Hajitou A; Rangel R; Trepel M; Soghomonyan S; Gelovani JG; Alauddin MM; Pasqualini R; Arap W
    Nat Protoc; 2007; 2(3):523-31. PubMed ID: 17406616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hybrid vector for ligand-directed tumor targeting and molecular imaging.
    Hajitou A; Trepel M; Lilley CE; Soghomonyan S; Alauddin MM; Marini FC; Restel BH; Ozawa MG; Moya CA; Rangel R; Sun Y; Zaoui K; Schmidt M; von Kalle C; Weitzman MD; Gelovani JG; Pasqualini R; Arap W
    Cell; 2006 Apr; 125(2):385-98. PubMed ID: 16630824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin Improves Cancer Cell Targeting by Filamentous Phage Gene Delivery Vectors.
    Tsafa E; Bentayebi K; Topanurak S; Yata T; Przystal J; Fongmoon D; Hajji N; Waramit S; Suwan K; Hajitou A
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural dietary genistein boosts bacteriophage-mediated cancer cell killing by improving phage-targeted tumor cell transduction.
    Tsafa E; Al-Bahrani M; Bentayebi K; Przystal J; Suwan K; Hajitou A
    Oncotarget; 2016 Aug; 7(32):52135-52149. PubMed ID: 27437775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies.
    Staquicini FI; Smith TL; Tang FHF; Gelovani JG; Giordano RJ; Libutti SK; Sidman RL; Cavenee WK; Arap W; Pasqualini R
    Cancer Gene Ther; 2020 May; 27(5):301-310. PubMed ID: 31130731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation of targeted AAVP vectors for systemic transgene delivery against cancer.
    Suwan K; Yata T; Waramit S; Przystal JM; Stoneham CA; Bentayebi K; Asavarut P; Chongchai A; Pothachareon P; Lee KY; Topanurak S; Smith TL; Gelovani JG; Sidman RL; Pasqualini R; Arap W; Hajitou A
    Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18571-18577. PubMed ID: 31375630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of histone deacetylation and DNA methylation improves gene expression mediated by the adeno-associated virus/phage in cancer cells.
    Kia A; Yata T; Hajji N; Hajitou A
    Viruses; 2013 Oct; 5(10):2561-72. PubMed ID: 24153059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of extracellular matrix in cancer is associated with enhanced tumor cell targeting by bacteriophage vectors.
    Yata T; Lee EL; Suwan K; Syed N; Asavarut P; Hajitou A
    Mol Cancer; 2015 Jun; 14():110. PubMed ID: 26037383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastoma.
    Przystal JM; Waramit S; Pranjol MZI; Yan W; Chu G; Chongchai A; Samarth G; Olaciregui NG; Tabatabai G; Carcaboso AM; Aboagye EO; Suwan K; Hajitou A
    EMBO Mol Med; 2019 Apr; 11(4):. PubMed ID: 30808679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome inhibition in cancer is associated with enhanced tumor targeting by the adeno-associated virus/phage.
    Przystal JM; Umukoro E; Stoneham CA; Yata T; O'Neill K; Syed N; Hajitou A
    Mol Oncol; 2013 Feb; 7(1):55-66. PubMed ID: 22951279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An AAVP-based solid-phase transducing matrix for transgene delivery: potential for translational applications.
    Smith TL; Souza GR; Sidman RL; Arap W; Pasqualini R
    Cancer Gene Ther; 2017 Aug; 24(8):358-360. PubMed ID: 28548103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas.
    Smith TL; Yuan Z; Cardó-Vila M; Sanchez Claros C; Adem A; Cui MH; Branch CA; Gelovani JG; Libutti SK; Sidman RL; Pasqualini R; Arap W
    Proc Natl Acad Sci U S A; 2016 Mar; 113(9):2466-71. PubMed ID: 26884209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor vasculature-targeted delivery of tumor necrosis factor-alpha.
    Tandle A; Hanna E; Lorang D; Hajitou A; Moya CA; Pasqualini R; Arap W; Adem A; Starker E; Hewitt S; Libutti SK
    Cancer; 2009 Jan; 115(1):128-39. PubMed ID: 19090007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses.
    Work LM; Büning H; Hunt E; Nicklin SA; Denby L; Britton N; Leike K; Odenthal M; Drebber U; Hallek M; Baker AH
    Mol Ther; 2006 Apr; 13(4):683-93. PubMed ID: 16387552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
    Staquicini DI; Tang FHF; Markosian C; Yao VJ; Staquicini FI; Dodero-Rojas E; Contessoto VG; Davis D; O'Brien P; Habib N; Smith TL; Bruiners N; Sidman RL; Gennaro ML; Lattime EC; Libutti SK; Whitford PC; Burley SK; Onuchic JN; Arap W; Pasqualini R
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34234013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells.
    Shayakhmetov DM; Carlson CA; Stecher H; Li Q; Stamatoyannopoulos G; Lieber A
    J Virol; 2002 Feb; 76(3):1135-43. PubMed ID: 11773389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.
    Lieber A; Steinwaerder DS; Carlson CA; Kay MA
    J Virol; 1999 Nov; 73(11):9314-24. PubMed ID: 10516040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified infusion procedures affect recombinant adeno-associated virus vector type 2 transduction in the liver.
    Ohashi K; Nakai H; Couto LB; Kay MA
    Hum Gene Ther; 2005 Mar; 16(3):299-306. PubMed ID: 15812225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.